RDDT Poised for Double‑Digit EPS Beat, $300 Target
There's another piece of alt data out today which shows $RDDT growing Q2 ad revenues at 59-60% YoY vs sell side at 47% YoY. $RDDT ad revenues are usually 93-94% of total revenues... this implies $RDDT might be on track to report $790-800M in Q2 revs vs sell side estimates at $729M If $RDDT beats consensus by 9-10% on the top line, they probably beat by way more on the bottom line because they have 90% gross margins. if $RDDT does $790-800M in Q2 and net income margins come in at 42% (similar to Q1), then there's a path to $1.75 EPS or better (depending on stock buybacks)... vs sell side at $1.45 EPS (20% beat) So, whatever their revenue % beat in Q2, it's very likely their eps % beat is 2x bigger. I'm very confident this is a $300 stock in the next 6-12 months. NFA. DYOR. *We own $RDDT at @FirstWaveFund, it's one of our biggest positions
Quality Small‑Caps Outperform Long‑Term, Risk‑On Spike Fades
The chart is essentially a 15-year case study in the small-cap quality premium. Quality matters in small caps. The persistent decline in the ratio confirms that the S&P 600's ($VIOO) earnings screen has been a meaningful edge over 15 years. Russell 2000's...
Rocket Lab’s Space Systems Drive Valuation Amid Losses
$RKLB is up another 3.4% today Between Rocket Lab and $RDW ... the space sector is showing serious relative strength this week When you look at RKLB ... don't focus on the launch cadence Focus on their space systems division That is where...
Investor Conference Surge Highlights TMD
It's a big month for investor conferences... many of our top holdings are presenting multiple times. Yesterday it was $HIMS, $TMDX, $MDB, $PRCT, $CIFR and several others. Today it's $CRDO, $ALAB, $APP, $RDDT, $HROW, $PLTR, $NBIS, $CRWV, $EOS, $RBRK, $LITE...
OMDA: Undervalued Digital Health Stock, Target $30
$OMDA is the most undervalued digital health play on the market right now Morgan Stanley has a $30 target on this.... trading under $18 They just raised their 2026 revenue guidance.. do the math 🤷♂️
IGV Hits 0.618 Fib, Targets $101 Resistance
$IGV bounced perfectly in early April off the .618 fibs... after a 35% rally from those lows it's very possible the .236 fibs is resistance ($101) so we just sold half of our $IGV swing trade https://t.co/lgTKytFsfj
Cash‑rich PBSV Undervalued; RCAT Overvalued Despite Losses
🕵️Operation $PBSV🕵️ The set-up: https://t.co/kShE7iG8aS shows me PBSV & $RCAT are less than 15 miles from my beachhead in San Juan. #Claude analyzes PBSV data - Perennial underperformer with TBV ~$0.52, where liquid assets (cash + Treasuries) represent ~92% of TBV, vs a...
AMPY Emerges Cash‑rich, Focused on Two Assets at 0.4x Book
Anyone following $AMPY? To summarize the last 12 months at this small-cap E&P... 1) Terminated merger 2) CEO replaced 3) Sold assets 4) Now have a net cash balance sheet, 5) Doubling down on remaining 2 assets (capex) 6) Trades at ~0.4x book value https://t.co/dkYRTB8sd7
IMMX Russell 2000 Addition Tight
$IMMX added to the Russell 2000 is exactly the type of setup that can tighten float dynamics fast. Passive buying. More institutional screens. More forced attention. Meanwhile NXC-201 data keeps improving and the market still doesn’t fully appreciate the AL amyloidosis opportunity.
V2X Free, 11% FCF Yield—Buy the Dip
V2X (VVX) is now free from its PE overhang. With a $13B backlog and an 11% FCF yield, this defense stock looks too cheap. Time to buy the dip? 🛡️ DefenseStocks
RELL Returns as Power‑Solutions Narrative Gains Momentum
Excerpt from @GeoInvesting Weekly Wrap-Up being published tonight: Well, I didn’t think I would be doing this anytime soon, but $RELL is back on our radar due to recent news about its expanding role in the power solutions narrative, including data...
AI‑HBM Boom Fuels Camtek Growth; Hold, Buy on Dip
AI-driven HBM demand underpins Camtek growth; strong margins, 26% 5y CAGR. Valuation trades at ~40x '27 EPS and China/regulatory exposure risks. Consider Hold with buy on pullback to <$110. — Viktor Kopylov, PhD, CFA More insights: t.me/si14Kopylov
VTech Posts Strong FY2026 Gains, Cautious FY2027 Outlook
VTech wrapped FY2026 strong—revenue up 4.6% to $2.12B, net profit climbing 18%. The 20th straight year of dividend growth? 👏 FY2027 outlook is more cautious: tariffs & costs pressuring margins, but modest revenue growth expected. Shifting production out of China. VTechEarnings
Seeking Undervalued Small‑Cap with Strong Fundamentals and Institutional Support
Hey @grok Which small-cap stock has the best combination of strong fundamentals, institutional accumulation, and low Wall Street coverage right now?
Badger Meter Unveils 2025 Smart Water Roadmap
Badger Meter just dropped their Analyst Day transcript. Key insights on their smart water strategy, growth plans, and tech roadmap for 2025. A must-read for anyone watching $BMI. WaterTech